Dr. Holladay serves as ASCPâ€™s Chief Executive Officer. He joined the ASCP in July of 2005. Since his tenure at ASCP, he has focused on globalization initiatives, strategic partnerships in laboratory medicine, corporate reorganization/management activities, mergers and acquisitions, international outreach, external partnerships (including the latest with the USCAP) and health services research and delivery. During his tenure, ASCP has been funded for over 30 million dollars to support patient-centered care. His scientific research work focuses in the areas of cytopathology, molecular research, clinical trials, novel methods for determining the standard of care in cancer cytopathology and improvement of laboratory administration. Funded as a Principal Investigator for 50 scientific research grants and over 100 scientific corporate contracts, Dr. Holladay has also published a number of significant research articles within the profession (n=50) and is the primary author of several textbooks that are national and international best sellers. He is an active scientific lecturer and has given over 140 national and international speeches.
E. Blair Holladay(Research Area)
Pathology, Clinical Pathology, cytopathology, molecular research, clinical trials, novel methods for determining the standard of care in cancer cytopathology and improvement of laboratory administration.
Dr. Anthony O. Okorodudu has been with the University of Texas System (UTMB) since 1989. He is a Distinguished Professor of Pathology and Director for services/programs. Anthony O Okorodudu completed his Doctorate degree in Pathology from University of Medicine and Dentistry of New Jersey and Post-doctoral studies in Clinical Chemistry from Hartford Hospital, Ct, USA. He is the Medical Director of Clinical Chemistry Division at the University of Texas Medical Branch and Medical Director of Laboratory Services for the UTMB/Correctional Managed Care System. He has trained 25 Doctoral students and Post-doctoral fellows and several pathology residents. His publication record includes 100+ peer reviewed publication in reputed journals and 11 book chapters. He currently serves on Editorial Board of two scientific journals and he has served on the board of directors for several scientific organizations.
Anthony O. Okorodudu(Research Area)
Chemical Pathology, Perturbation of intracellular cations in response to drugs/diseases and research and development to support introduction of new diagnostic systems
Jianhua Luo been studying molecular pathology related to human malignancies in the last 23 years. Currently, he is a Professor of Pathology and Director of High Throughput Genome Center at University of Pittsburgh. In the last 13 years, Dr. Luo has been largely focusing on genetic and molecular mechanism of human prostate and hepatocellular carcinomas. In this period, his group has identified and characterized several genes that are related to prostate cancer and hepatocellular carcinoma, including SAPC, myopodin, CSR1, GPx3, ITGA7, MCM7, MT1h and GPC3. He has characterized several signaling pathways that play critical role in prostate cancer development, including Myopodin-ILK-MCM7 inhibitory signaling, myopodin-zyxin motility inhibition pathway, CSR1-CPSF3 and CSR1-XIAP apoptotic pathways, MT1h-EHMT1 egigenomic signaling, ITGA7-HtrA2 tumor suppression pathway, GPx3-PIG3 cell death pathway, and AR-MCM7 oncogenic pathway. He proposed prostate cancer field effect in 2002. He is one of the pioneers in utilizing high throughput gene expression and genome analyses to analyze field effects in prostate cancer and liver cancer. He is also the first in using methylation array to analyze prostate cancer. Recently, his group found that patterns of copy number variants of certain specific genome loci, are predictive of prostate cancer clinical outcomes, regardless tissue origin. Overall, these findings advance our understanding onhow cancer develops and behaves, and lay down the foundation for better future diagnosis and treatment of human malignancies.
Jianhua Luo(Research Area)
Gene expression; genomics; prostate cancer; signal transduction; biomarkers; molecular diagnostics
Dr. Rizwan completed my Cytogenetics and Molecular fellowships from Harvard University and Boston University. I am dual board certified by the American Board of Medical Genetics in Clinical Molecular Genetics and Clinical Cytogenetic. I am a CLIA, CAP and NY State certified lab director
In 2009 I developed a diagnostic genetics fellowship program at the Montefiore Medical Center and Albert Einstein College of Medicine.
I oversee operations of the molecular pathology laboratory testing and training. I play a leadership role in developing an integrated program of genetic diagnostics that promotes the application of genomic technologies in health management, from genome discovery to evaluation of medical impact and clinical utility.
I have developed and have directly overseen the overall operations of the Clinical and Research Core Cytogenetics/Molecular Laboratories. I supervise technical and non-technical staff. I am directly responsible for the startup of new genetic testing, technology evaluation, QA/QC, budget planning, equipment purchasing, and marketing. I also supervise students, MD and PhD fellows, and other trainees in the laboratory.
I have worked as a consultant at the World Health Organization (WHO) Genetics division and CAP International to inspect laboratories and genetic programs around the world.
I effectively lead and manage cross functional and multidisciplinary teams which have consistently resulted in timely completion of projects. I have assisted in the development of cross institutional collaborations for research purposes, reviewing grants and external manuscripts, etc.
I started a free of cost genetic diagnostic laboratory for childhood leukemia at the National institute of Child Health in Karachi Pakistan. Received a competitive grant from NSA to help develop a satellite based Tele-healthcare teaching and training modules. I served as director of international NGO Human Develop Foundation.
Dr. Liang Cheng is inaugural Virgil H. Moon Endowed Professor of Pathology and Urology at Indiana University School of Medicine, Indianapolis, Indiana, USA. Currently, he is Chief of the Genitourinary Pathology Service, Director of the Urologic Pathology Fellowship, and Director of Molecular Diagnostics and Molecular Pathology Laboratories. Dr. Cheng is board certified in Molecular Genetic Pathology, Anatomic and Clinical Pathology by the American Board of Pathology. Dr. Cheng has received numerous prestigious awards including the Stowell-Orbison Award from the United States and Canadian Academy of Pathology (USCAP) and the Koss Medal Award from the International Society of Urological Pathology (ISUP). Dr. Cheng received the Arthur Purdy Stout Prize from the Arthur Purdy Stout Society of Surgical Pathologists in recognition of outstanding contributions to the field of surgical pathology for a surgical pathologist less than 45 years old. Dr. Cheng has published over 820 peer-reviewed SCI articles in high-impact scientific journals. His published work has been cited more than 30,000 times (ISI Web of Science h-index: 92). He is also the author of over 100 book chapters and several books, including Bladder Pathology, Urologic Surgical Pathology, Essentials of Anatomic Pathology, Molecular Genetic Pathology, Molecular Surgical Pathology, and Atlas of Anatomic Pathology (Series Editor). Currently, he is an active member of over 30 Editorial Boards, including Molecular Cancer (Associate Editor), Human Pathology (Senior Associate Editor), American Journal of Surgical Pathology, Modern Pathology, Histopathology, Journal of Pathology, Journal of Clinical Pathology, European Journal of Cancer, Pathology, Future Oncology, Urologic Oncology, Expert Review of Anticancer Therapy, Critical Reviews in Oncology/Hematology and others. Dr. Cheng's research focuses on translational studies of genitourinary cancers and molecular diagnostics of solid tumors.
Dr. Sarah Adelaide Crawford received a doctoral degree from Columbia University College of Physicians and Surgeons Department of Biochemistry and Biophysics. She received a Masterâ€™s Degree in biochemistry from Princeton University. Her post-doctoral research was carried out at Memorial Sloan Kettering Cancer Center in New York. Dr. Crawford is Professor of Genetics at Southern Connecticut State University and Director of the Cancer Biology Research Laboratory. In 2013, she was awarded two patents [USA, Canada and Europe] for developing novel combined chemotherapy approaches using a new plant extract formulation for brain tumors and other malignancies. Dr. Crawford has begun a new research initiative to study the causes and prevention of autism. She has developed a new model to explain the causes of autism and its recent dramatic increase. Applications of this model can be used in preventive approaches to screen for autism risk factors to reduce the occurrence of this disorder.
Her past and present professional associations include membership in the American Association for Cancer Research (AACR),the the European Association for Cancer Research (EACR), Harvard Medical School Postgraduate Association, American Medical Writer's Association, Society for Clinical Research Associates (SOCRA), and the American Association for the Advancement of Science (AAAS).
Dr. Antic is an Associate Professor and the Director of Cytopathology at the University of Chicago, USA. She is fellowship trained in genitourinary pathology as well as cytopathology at the MD Anderson Cancer Center and is a certified member of American Board of Pathology and Cytopathology. She oversees the Cytopathology Fellowship program at UOC and has mentored several fellows over the past several years. She is a member of the American Society of Clinical Pathology CheckPath Committee and the chair of American Society of Cytopathology Clinical Practice Committee. She has published over 70 research papers in various peer-reviewed top-rated journals including the American Journal of Surgical Pathology and Nature. In addition, she has written several book chapters and authored a book titled â€œRenal Neoplasms: an Integrative Approach to Cytopathologic Diagnosisâ€ published in 2014 and very well received. Dr. Anticâ€™s research interest is in the area of kidney and urothelial carcinoma.
Apt received her Ph.D. in Sociology from Northeastern University in Boston, Massachusetts (USA), her Masters in Sociology from Boston University in Boston, Massachusetts (USA), and her Bachelors in Sociology from Indiana University in Indianapolis, Indiana (USA). She also has a Certificate of French Studies from Ecole Lemania in Lausanne, Switzerland. As she was finishing her coursework at Northeastern University, she learned that she was the recipient of an internship in Applied Medical Sociology from the American Sociological Association. She chose to assume this honor at the University of Texas Medical School, Department of Psychiatry, in San Antonio, Texas, where she worked for 2 years. During this time she did HIV/AIDS research and wrote HIVAIDS education materials which she and her staff used with high-risk individuals incarcerated in the county jail in San Antonio. During this time she also taught at the University of Texas at San Antonio, and team taught a course in psychiatric interviewing for medical students during their second-year psychiatry rotation. Dr. Apt has taught courses in Medical Sociology, Human Sexuality, and the Sociology of Genocide. She is also the host of a live, call-in radio program called â€œTalk to Me,â€ which is broadcast on 90.3 FM-WSSB in South Carolina. The subject of her radio show is sexuality and relationships.
Apt currently holds the elected offices of vice president and member of the board of directors of the Action Council for Cross-Cultural Mental Health and Human Services, a statewide organization dedicated to enhancing the involvement of culturally diverse citizens in the management, delivery and utilization of mental health and human services. She is also a consultant to the South Carolina Medical Association Bioethics Committee and a member of the Ethics Committee of the Regional Medical Center in Orangeburg, S.C.
Carol Apt(Research Area)
Medical Sociology, Social Pathology, Global Health Care, Social and Behavioral Science
Dr. Qing Kay Li is an associate professor of department of pathology at the Johns Hopkins University School of Medicine. She has the American Board of Pathology certification in anatomic and clinical pathology, and subspecialty certification in cytopathology. Her areas of clinical expertise include surgical pathology, cytopathology, and oncological pathology. Dr. Li is also a faculty member and co-PI at the Johns Hopkins Biomarker Discovery Center. Her research interests is focusing on the application of advanced cellular and molecular techniques to the field of cytopathology and cancer biology, particularly in the field of early detection of lung and prostate cancer. Dr. Li serves as editorial board members for several journals; committee members of the American Society of Cytopathology, Papanicolaou Society of Cytopathology, NIH/NCI lung cancer and kidney cancer working group; study sections of government agents and private organizations. She has more than 120 publications, including several book chapters and books. She has served as a keynote speaker at national and international meetings.
Qing Kay Li(Research Area)
Genetic biomarkers, Lung cancer, Early detection of lung and prostate cancer.
Dr. Zahra Maleki is an associate professor of pathology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include surgical pathology and cytopathology. Her priority as a clinician and pathologist is to serve the patients by performing both fine needle aspirations and on site evaluations of specimen adequacy, and providing an accurate, timely diagnosis. She teaches and mentors fellows, residents, and students at the Johns Hopkins School of Medicine.
She received her medical degree from Shaheed Beheshti University of Medical Sciences and completed a residency in anatomic and clinical pathology at the Virginia Commonwealth University School of Medicine. She performed her first fellowship at the Virginia Commonwealth University School of Medicine in pathology and a second fellowship in cytopathology at the University of Miami.
Dr. Maleki's research interests include head/neck and lung neoplasms. She is investigating the role of human papilloma virus (HPV) in head and neck squamous cell carcinomas.
She is board-certified in anatomical pathology, clinical pathology and cytopathology. She has published papers in surgical pathology and cytopathology.
Zahra Maleki(Research Area)
Translational studies in lung neoplasms, head/neck neoplasms,
Dr. Liam Chen is an assistant professor of pathology at the Johns Hopkins University School of Medicine. His research focuses on understanding the pathogenesis of neurodegenerative disorders and CNS tumors. His primary clinical involvement is on the neuropathology service. Dr. Chen earned his M.D. from Shandong Medical University in China and his Ph.D. from the University of Alberta in Canada. He was subsequently a postdoctoral fellow at Harvard Medical School, and completed Anatomic Pathology/Neuropathology training at Brigham and Womenâ€™s Hospital, Boston Children's Hospital and a Molecular Genetic Pathology fellowship at Harvard Medical School.
Liam Lucian Chen(Research Area)
Pathogenesis of Neurodegenerative Disorders, Developing diagnostic markers and validating therapeutic targets, Anatomic Pathology, Molecular Genetic Pathology, Neuropathology, Pathology
Dr. Venkataraman is an Assistant Professor and Medical Director of Immunohistochemistry at the Department of Pathology in University of Chicago, USA He is a certified member of American Board of Pathology/ Anatomic and Clinical Pathology and the American Board of Pathology-Hematology and is currently serving as the Editor-in-Chief of the American Society of Hematology Image Bank and vice-president of the Chicago Pathology society. He has published over 50 research papers in various peer-reviewed reputed journals including Blood and written book chapters for several books including the upcoming WHO IARC Blue on Skin tumors.
Girish Venkataraman(Research Area)
prognostic biomarkers in classical Hodgkin lymphoma (cHL), immunohistochemistry, hematopathology, bone marrow biopsies/aspirates, lymph node biopsies, body fluid/CSF analysis
Deyin Xing, M.D., Ph.D., joined our faculty as an assistant professor in the Division of Gynecologic Pathology in July 2016. Dr. Xing earned his medical degree in 1999 from Nankai University in Tianjin, China. Following medical school, he spent three years completing a doctoral degree in oncology at Peking Union Medical College in Beijing. In 2003, he joined the laboratory of Dr. Sandra Orsulic as a research fellow in the department of pathology at the Massachusetts General Hospital/Harvard Medical School.
Dr. Xingâ€™s research focused on the development of genetically engineered mouse models of ovarian cancer and of leiomyosarcoma. These mouse models, designed to recapitulate the human disease, provided insight into the initiation, progression and targeted therapies of ovarian cancer and leiomyosarcomas. In 2007, Dr. Xing joined the laboratory of Nobel Prize laureate Dr. Phillip Sharp at the David H. Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology. As a postdoctoral associate, his translational research at MIT involved the delivery of siRNAs to silence genes in genetically defined murine ovarian tumor models.
Dr. Xing resumed his clinical career as an anatomic pathology resident in 2011 in the department of pathology at the University of Alabama at Birmingham. In 2014, he came to Hopkins and completed a gynecologic pathology fellowship. Dr. Xingâ€™s clinical and translational research will focus on novel diagnostic and prognostic markers of gynecologic neoplasms, pathway and molecule-based personalized medicine, and cancer epigenetics.
Dr. Stephan C. Schafer is the head of Pneumopathology, University Hospital Cologne, Germany. Dr. Stephan Schafer provides training in the field of interstitial pulmonary diseases for pathologists and radiologists, and is responsible for our consile entrance for lung diseases.
Prof. Timo Gaiser is the Chief Medical Officer of Pathology, Director of Molecular Pathology, University Medical Center Mannheim, Germany since 2012. He completed his Ph D from Institute of Pathology, University of LÃ¼beck in 2012. He is a member of International Academy of Pathology, Section Germany Professional Association of German Pathologists, and Unites States & Canadian Academy of Pathology. He is a reviewer of Journal of Investigative Dermatology, International Journal of Cancer, Plos one, Melanoma Research, Microscopy Research and Technique, Histology and Histopathology and Editorial board member of : International Journal of Clinical and Experimental Pathology.
Timo Gaiser(Research Area)
Pathology, Molecular Pathology, Immunohistochemistry, and Neuropathology
Prof. Dr. Jochen Fries is the head of a translational pathology laboratory, University Hospital of Cologne, Germany, focusing on the role of endothelin-1, its signal transduction and the function of its newly defined target genes in renal and urogenital pathology. He has published more than 60 research paper in various international journals in the field of Chronic Renal Disease, Cardiac Disease / Vascular Disease, Molecular Therapy / Transplantation Technology/ Stem Cell Technology. He was trained in Surgical Pathology at the Brigham and Womenâ€™s Hospital and obtained postdoctoral training at the Brigham and Womenâ€™s Hospital, Childrenâ€™s Hospital, and Harvard School of Public Health in Boston.
Professor Uta Drebber is the head of Reference Center Hepatopathology, University Hospital Cologne, Germany. She conducted numerous tutorials in the field of liver pathology within the framework of the German Department of the International Academy of Pathology (IAP) and is a long-standing member of the international expert group of the Laennec Liver Pathology Society. Within the framework of national and international co-operation, the topics of hepatitis of different etiology and metabolic diseases are the focus of research. Professor Uta Drebber is the author and co-author of numerous scientific publications. She is the author Miglied group of German S3 guideline for NAFLD and the S3 guideline for hepatitis C .
Giuseppe Scalabrino studied at the School of Medicine of the University of Milan and received his M.D. degree magna cum laude in 1968. He has held a number of academic positions in the Faculty of Medicine of the University of Milan. He was Associate Professor of General Pathology between 1971 and 1985; full Professor of General Pathology from 1986 till 2014. He has been invited speaker in various conferences, mainly dealing with the role of polyamines in oncology and subsequently with the cobalamin (vitamin B12) neurotrophism. Among his numerous honors, he received the International Award "Roentgen" from Italian Accademia dei Lincei in Rome for oncological research in 1983. He is author of more than 100 scientific papers and reviewer of numerous International Journals. Dr. Scalabrino's studies of cobalamin neurotrophism have been mentioned and reviewed in 12 american textbooks of neurology, biochemistry, hematology, and vitaminology.
MarÃa Amparo Lopez-Ruiz is a Professor of Human Anatomy, Department of Biomedicine, Health Science Faculty, UCH-CEU. Moncada (Valencia), Spain Since 2010. She has completed her PhD from Valencia University and Post-doctoral studies from the CEU Cardenal Herrera University. She completed her Doctorate in Medicine with thesis entitled: Analysis of the use of medication in the pediatric population that visits accident and emergency department. She has been a Medical Degree Coordinator at CEU Cardenal Herrera University since 2015. She has attended international congresses of pediatrics as a Keynote Speaker and has published more than 20 papers in reputed journals.
Maria Amparo Lopez Ruiz(Research Area)
Newborn Pathology, Cardiac and Respiratory Pathology, Nutrition and Newborn Nutrition of the Neonate for nursing
Sergey Suchkov graduated from Astrakhan State Medical University and was awarded with MD.In 1985, Suchkov obtained his Ph.D. As a Ph.D. student of the I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology, USSR Academy of Medical Sciences, Moscow, Russia. In 2001, Suchkov finished the PostDoc Research Fellowship Program and maintained his Doctor Degree at the National Institute of Immunology, Russia. From 1987 through 1989, Dr. Suchkov was a senior Researcher, Lab of Developmental Immunology, Koltzov Institute of Developmental Biology, USSR Academy of Sciences to deal to developmental immunology. From 1989 through 1995, Dr. Suchkov was being a Head of the Lab of Clinical Immunology and Im-munobiotechnology, Helmholtz Eye Research Institute in Moscow. From 1995 through 2004, Dr. Suchkov was being a Chairman of the Department for Clinical Immunology, Moscow Clinical Research Institute (MONIKI) and the Immunologist-in-Chief of the Moscow Regional Ministry of Health. At present, Dr Sergey Suchkov, M, Ph.D., is Professor in Immunology, Department of Pathology, School for Pharmacy, I.M. Sechenov First Moscow State Medical University, Dean of the Department (Faculty) of The PPPM Development, and the First Vice-President of the University of World Business, Politics and Law and Secretary General, United Cultural Convention (UCC), Cambridge, UK.
Marcio Alvarez-Silva was graduated in Pharmacy at the Federal University of Rio de Janeiro and PhD in Sciences at the Federal University of Rio de Janeiro. He is currently a Professor at the Federal University of Santa Catarina and coordinates the Laboratory of Stem Cell and Bioengineering at the Department of Cell Biology, Embryology and Genetics.
Dr. Li completed his MD and PhD degrees and Oncological and Breast Pathology Fellowship at MD Anderson Cancer Center. He is currently the Lead Breast Pathologist, Assistant Professor of Pathology, Associate Director of Glenn Family Breast Center and Glenn Family Breast Cancer Tissue Bank of Winship Cancer Institute, Emory University. Dr. Li is frequently invited to speak and give lectures at National/International conferences. He has published more than 35 papers in reputed journals.
Anna Dunnigan studied pre-clinical medicine at the University of Cambridge, and clinical medicine at the University of Oxford. She is originally from London, and now works as a foundation doctor at Milton Keynes University Hospital, which is part of the Oxford Deanery. As well as her interests in pathology, Anna has a strong interest in education, and is currently studying for a long-distance degree in Medical Education with the University of Dundee. She is also very interested in patient safety and has undertaken numerous quality improvement projects in this area, presented at both regional and national level.